Argenx Se ARGX
NASDAQ ARGX
$818.95 -27.32 (-3.23%)
As of: Oct 16, 2026 · 3:59 PM EDT

Argenx Se (ARGX) Current Leases (2019 - 2021)

Updated

Argenx Se (ARGX) reported Current Leases of $11 million for Q2 2026, down 99.9% from $7.58 billion a year earlier.

Analysis

Argenx Se (ARGX) Current Leases (2019 - 2021) Analysis & Trends

Dating back to Q2 2019, Argenx Se's Current Leases record includes 15 quarters.

  • Current Leases has a five-year compound annual growth rate of -68.4% (FY2020 to FY2025).
  • By year, Current Leases came in at $6.53 billion in FY2024, $4.65 million in FY2023 (-99.9%), $3.42 billion in FY2022 (-2.6%) and $3.51 billion in FY2021 (+0.9%).
  • Five-year quarterly Current Leases spans a low of $3.2 million in Q2 2023 and a high of $7.58 billion in Q2 2025.
  • The high point for year-over-year Current Leases in five years was Q2 2024 (growth of 83.0%); the low point was Q4 2023 (a decline of 99.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn -
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Argenx Se 50.23 Bn 34.19 Bn 1.37 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 3.51 Bn
Jun 30, 2021 3.45 Mn
Dec 31, 2020 3.48 Bn
Jun 30, 2020 2.54 Mn
Dec 31, 2019 2.21 Mn
Jun 30, 2019 1.23 Mn
API Access

Argenx Se Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ARGX&period=max&api_key=YOUR_API_KEY